The Phase 3 Illuccix China study [1] is a prospective, open-label, single-arm, multicenter study conducted in collaboration with Telix's strategic partner for the Greater China region, Grand ...

Mumbai: Maharashtra Chief Minister Eknath Shinde and Deputy Chief Minister Devendra Fadnavis inaugurated Phase 2A of Mumbai Metro Line 3 on Friday, marking a significant milestone in the city’s ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

According to DOTD, motorists will see more changes this week. The I-20 project is in phase 3, meaning drivers are closer than ever to being able to drive on a resurfaced interstate. "So I-20 is ...

Please provide your email address to receive an email when new articles are posted on . Sotyktu significantly improved skin and joint symptoms of psoriatic arthritis and reduced patient-reported ...

Credit: SpaceX COLORADO SPRINGS — The U.S. Space Force’s Systems Command has assigned the first nine National Security Space Launch (NSSL) missions under the Phase 3 Lane 2 contracts ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is currently evaluating mavorixafor in a Phase 3 clinical trial in chronic neutropenia (CN) patients. The 4WARD trial is expected to enroll a total of 150 ...

The New York City central nervous system (CNS) specialist has scored in a phase 3 trial testing Sunosi (solriamfetol) on adults with attention deficit hyperactivity disorder (ADHD). The study ...

Findings showed statistically significant reductions in the ADHD Investigator Symptom Report Scale total score were seen with solriamfetol 150mg vs placebo at week 6. Topline data were announced ...

The phase 3 OVATION 3 trial will evaluate IMNN-001's efficacy and safety in advanced ovarian cancer patients, comparing it with standard chemotherapy. Phase 2 results demonstrated a 35% improvement in ...

BENGALURU: While the land acquisition process for Bengaluru Metro’s Phase-3, approved by the Centre and State, has been speeded up by splitting it into four packages, a crucial parcel of land ...

Incyte took the candidate into phase 3 trials in the skin condition hidradenitis suppurativa (HS) after seeing (PDF) placebo-adjusted response rates of up to 27.7% in a mid-stage study.